Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: A randomized, double-blind, placebo-controlled trial

Depression and Anxiety

Volumn 32, Issue 3, 2015, Pages 167-173

  Zeinoddini, Atefeh ^a   Sorayani, Maryam ^a   Hassanzadeh, Elmira ^a   Arbabi, Mohammad ^a   Farokhnia, Mehdi ^a   Salimi, Samrand ^b   Ghaleiha, Ali ^c   Akhondzadeh, Shahin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

bipolar disorder; depression; pioglitazone; PPAR gamma; randomized controlled trial; thiazolidinedione

Indexed keywords

LITHIUM; PIOGLITAZONE; PLACEBO; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDEPRESSANT AGENT;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; ANALYSIS; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EDEMA; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; HYPOMANIA; LITHIUM BLOOD LEVEL; LIVER DISEASE; MAJOR DEPRESSION; MALE; MENTAL PATIENT; METABOLIC SYNDROME X; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; REPEAT PROCEDURE; RESPIRATORY TRACT DISEASE; WEIGHT GAIN; YOUNG MANIA RATING SCALE; AGED; BIPOLAR DISORDER; DEPRESSION; DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; THIAZOLIDINEDIONES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923687628     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22340     Document Type: Article

References (32)

1. Calabrese JR, Hirschfeld RM, Frye MA, Reed ML,. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry 2004; 65: 1499-1504.
2. Simon GE, Bauer MS, Ludman EJ, Operskalski BH, Unützer J,. Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J Clin Psychiatry 2007; 68 (8): 1237-1245.
3. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
4. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010; 11: 81-109.
5. Nivoli AM, Colom F, Murru A, et al. New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord 2011; 129: 14-26.
6. Association AP,. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159 (4 Suppl): 1-50.
7. Machado-Vieira R, Salvadore G, Luckenbaugh DA, et al. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry 2008; 69: 946-958.
8. Jick H, Kaye JA, Jick SS,. Antidepressants and the risk of suicidal behaviors. JAMA 2004; 292: 338-343.
9. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-255.
10. Spiegelman BM,. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507-514.
11. Kaiser CC, Shukla DK, Stebbins GT, et al. A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis. J Neuroimmunol 2009; 211: 124-130.
12. Miller BW, Willett KC, Desilets AR,. Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease. Ann Pharmacother 2011; 45: 1416-1424.
13. Kemp DE, Ismail-Beigi F, Ganocy SJ, et al. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord 2012; 136: 1164-1173.
14. Kemp DE, Schinagle M, Gao K, et al. PPAR-gamma agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression. CNS Drugs 2014; 28 (6): 571-581.
15. Kemp DE, Gao K, Chan PK, et al. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 2010; 12: 404-13.
16. Kemp DE, Ismail-Beigi F, Calabrese JR,. Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am J Psychiatry 2009; 166 (5): 619.
17. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, et al. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 2008; 69: 178-182.
18. Mathew SJ, Manji HK, Charney DS,. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008; 33: 2080-2092.
19. Salehi-Sadaghiani M, Javadi-Paydar M, Gharedaghi MH, et al. NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice. Psychopharmacology 2012; 223: 345-355.
20. Sepanjnia K, Modabbernia A, Ashrafi M, et al. Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial. Neuropsychopharmacology 2012; 37: 2093-2100.
21. Cuellar AK, Johnson SL, Winters R,. Distinctions between bipolar and unipolar depression. Clin Psychol Rev 2005; 25: 307-339.
22. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
23. Young RC, Biggs JT, Ziegler VE, Meyer DA,. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
24. Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
25. Zeinoddini A, Ahadi M, Farokhnia M, et al. L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial. J Psychiat Res 2014; 59: 125-131.
26. Amrollahi Z, Rezaei F, Salehi B, et al. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 2011; 129: 327-331.
27. Abolfazli R, Hosseini M, Ghanizadeh A, et al. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. Depress Anxiety 2011; 28: 297-302.
28. Abbasi S-H, Hosseini F, Modabbernia A, et al. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord 2012; 141: 308-314.
29. Shahmansouri N, Farokhnia M, Abbasi S-H, et al. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. J Affect Disord 2014; 155: 216-222.
30. Kashani L, Omidvar T, Farazmand B, et al. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology 2013; 38: 767-776.
31. Sadaghiani MS, Javadi-Paydar M, Gharedaghi MH, et al. Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway. Behav Brain Res 2011; 224: 336-343.
32. Vlckova V, Cornelius V, Kasliwal R, et al. Hypoglycaemia with pioglitazone: analysis of data from the prescription-event monitoring study. J Eval Clin Pract 2010; 16: 1124-1128.